{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:03:22Z","timestamp":1771221802459,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.gene.2026.150031","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:25:27Z","timestamp":1769790327000},"page":"150031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PBX1-mediated transcription of AP1M2 promotes triple-negative breast cancer malignant progression and docetaxel resistance"],"prefix":"10.1016","volume":"987","author":[{"given":"Ruijie","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150031_b0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/etm.2020.8705","article-title":"PBX1 is a valuable prognostic biomarker for patients with breast cancer","volume":"20","author":"Ao","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.gene.2026.150031_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150031_b0015","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddn397","article-title":"Pre-B-cell leukemia homeobox 1 (PBX1) shows functional and possible genetic association with bone mineral density variation","volume":"18","author":"Cheung","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2026.150031_b0020","article-title":"Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC","volume":"23, 1665","author":"Ferrari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150031_b0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000500","article-title":"Epidemiology of triple-negative breast cancer: a review","volume":"27","author":"Howard","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.gene.2026.150031_b0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11626-008-9162-5","article-title":"PBX1 is dispensable for neural commitment of RA-treated murine ES cells","volume":"45","author":"Jurgens","year":"2009","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.gene.2026.150031_b0035","article-title":"PBX1 as a novel master regulator in cancer: its regulation, molecular biology, and therapeutic applications","volume":"1879","author":"Kao","year":"2024","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2026.150031_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115545","article-title":"Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies","volume":"212","author":"Karim","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2026.150031_b0045","article-title":"Discovering breast cancer biomarkers candidates through mRNA expression analysis based on the cancer genome atlas database","volume":"12, 1753","author":"Kim","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.gene.2026.150031_b0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071674","article-title":"Advances in systemic therapies for triple negative breast cancer","volume":"381","author":"Leon-Ferre","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.gene.2026.150031_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BST20191055","article-title":"Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis","volume":"48","author":"Lev","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.gene.2026.150031_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.31083\/j.fbl2907239","article-title":"An apoptosis-related specific risk model for breast cancer: from genomic analysis to precision medicine","volume":"29","author":"Li","year":"2024","journal-title":"Front. Biosci. (landmark Ed)"},{"key":"10.1016\/j.gene.2026.150031_b0065","article-title":"Targeting SPHK1\/PBX1 axis induced cell cycle arrest in non-small cell lung cancer","volume":"23, 12741","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150031_b0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cac2.12281","article-title":"m(6) A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun. (lond)"},{"key":"10.1016\/j.gene.2026.150031_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.1401851","article-title":"The murine Pbx1-d lupus susceptibility allele accelerates mesenchymal stem cell differentiation and impairs their immunosuppressive function","volume":"194","author":"Lu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2026.150031_b0080","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11864-019-0682-x","article-title":"Targeted therapies for triple-negative breast cancer","volume":"20","author":"Lyons","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.gene.2026.150031_b0085","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.2174\/0115701808297489240531111626","article-title":"Rheum khorasanicum decreases migration and induces apoptosis in the MDA-MB-231 breast cancer cell line","volume":"21","author":"Mitra","year":"2024","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.gene.2026.150031_b0090","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.stemcr.2021.09.016","article-title":"PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm","volume":"16","author":"Muggeo","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.gene.2026.150031_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000015391","article-title":"Genomic structure and chromosome mapping of the genes encoding clathrin-associated adaptor medium chains mu1A (Ap1m1) and mu1B (Ap1m2)","volume":"87","author":"Nakatsu","year":"1999","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.gene.2026.150031_b0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovic","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150031_b0105","doi-asserted-by":"crossref","first-page":"10318","DOI":"10.1073\/pnas.1300460110","article-title":"Arabidopsis mu-adaptin subunit AP1M of adaptor protein complex 1 mediates late secretory and vacuolar traffic and is required for growth","volume":"110","author":"Park","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150031_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101149","article-title":"RGS5(+) lymphatic endothelial cells facilitate metastasis and acquired drug resistance of breast cancer through oxidative stress-sensing mechanism","volume":"77","author":"Qiu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.gene.2026.150031_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132730","article-title":"Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer","volume":"274","author":"Sengupta","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.gene.2026.150031_b0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.gastro.2011.04.056","article-title":"The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice","volume":"141","author":"Takahashi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gene.2026.150031_b0125","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00109-021-02139-2","article-title":"PBX1: a key character of the hallmarks of cancer","volume":"99","author":"Veiga","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.gene.2026.150031_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148955","article-title":"Deciphering the influence of AP1M2 in modulating hepatocellular carcinoma growth and Mobility through JNK\/ErK signaling pathway control","volume":"933","author":"Wang","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.gene.2026.150031_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121795","article-title":"A chemo\/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy","volume":"329","author":"Wang","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.gene.2026.150031_b0140","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/acsbiomaterials.4c00108","article-title":"Nanoparticle-mediated immunotherapy in triple-negative breast cancer","volume":"10","author":"Wang","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.gene.2026.150031_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7945077","article-title":"System analysis of adaptor-related protein complex 1 subunit Mu 2 (AP1M2) on malignant tumors: a pan-cancer analysis","volume":"2022","author":"Yi","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.gene.2026.150031_b0150","first-page":"2438","article-title":"uc.38 induces breast cancer cell apoptosis via PBX1","volume":"7","author":"Zhang","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.gene.2026.150031_b0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1568009622666220413084456","article-title":"PBX1 participates in estrogen-mediated bladder cancer progression and chemo-resistance affecting estrogen receptors","volume":"22","author":"Zhao","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.gene.2026.150031_b0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-025-02355-1","article-title":"Clinical approaches to overcome PARP inhibitor resistance","volume":"24","author":"Zou","year":"2025","journal-title":"Mol. Cancer"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:10:36Z","timestamp":1771218636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"alternative-id":["S0378111926000405"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150031","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PBX1-mediated transcription of AP1M2 promotes triple-negative breast cancer malignant progression and docetaxel resistance","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150031"}}